To buy shares in Oceanethix International Holdings you’ll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you’ll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Read research reports, investor presentations, listen to earnings call and get recommendations from the best minds to maximise your gains. Click HereCompare OCX with any other stocks with the compare two stocks feature, or find the OCX earnings date withOCX earnings date. OCX is trading in the range of $1.14 – $1.68 in the past 30 days. This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.
OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. It develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers. In addition, the company also developing screening diagnostics as potential replacements for screening imaging procedures that do not meet the needs of patients, health care providers or payers.
Past performance is not a guarantee of future results, and a loss of original capital may occur. None of the information presented should be construed as an offer to sell or buy any particular security. According to 11 analysts, the average rating for OCX stock is “Buy.” The 12-month stock price forecast is 4.9, which is an increase of 267.04% from the latest price. The Company is engaged in developing and commercializing laboratory-developed tests to serve unmet medical needs across the cancer care continuum.
Highlights important summary options statistics to provide a forward looking indication of investors’ sentiment. Zacks Earnings ESP looks to find companies that have recently seen positive earnings estimate revision activity. The idea is that more recent information is, generally speaking, more accurate and can be a better nole network predictor of the future, which can give investors an advantage in earnings season. As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.
View analysts’ price targets for OncoCyte or view top-rated stocks among Wall Street analysts. Oncocyte is a molecular diagnostics company whose mission is to provide actionable answers at critical decision points across the cancer care continuum. The Company, through its proprietary tests and pharmaceutical services business, aims to help save lives and improve outcomes by accelerating and optimizing the diagnosis and treatment of cancer. The Company’s tests and services present multiple opportunities to advance cancer care while also driving revenue growth for the Company. Oncocyte has launched DetermaRx™, a test that identifies early-stage lung cancer patients who are at high risk for cancer recurrence post-resection and predicts benefit from adjuvant chemotherapy.
